Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Affymetrix and Tessare Develop Pathogen-Detection Kit

By HospiMedica staff writers
Posted on 12 Feb 2007
Affymetrix Inc. More...
(Santa Clara, CA, USA) announced that it has granted Tessare, Inc. (Colorado Springs, CO, USA) non-exclusive access to its microarray technology to develop and market epidemiological tests for public health and biodefense surveillance.

As part of the Powered by Affymetrix program, the TessArray kits will detect and identify hundreds of strains of natural and emergent viral and bacterial pathogens, as well as biothreat agents. The resulting information will enable scientists to understand and respond to pandemic infectious disease threats.

The TessArray kits are based on multiplexed genotypic signatures present on the Affymetrix CustomSeq Resequencing Arrays. These arrays have been designed and fabricated to detect a set of upper respiratory pathogen-specific target sequences provided by the U.S. Naval Research Laboratory. Public health officials can use the resulting information to identify the most likely agent strain(s) associated with disease outbreaks.

Tessare president and co-founder Klaus Schafer, M.D., M.P.H., said, Investigators at collection sites can determine whether detected pathogen strains warrant elevated epidemic or pandemic concerns. The TessArray kits enable a level of strain and sub-strain discrimination not possible with other array-based methodologies, as well as the ability to detect and characterize novel nucleotide changes in the pathogen genome sequence at the same time.

With the recent emergence of new infectious diseases such as avian influenza, it is important for global health organizations to have access to comprehensive epidemiological surveillance research tools, said Robert Lipshutz, Ph.D., senior vice president, corporate development and emerging markets at Affymetrix. We are pleased to have Tessare join our Powered by Affymetrix program and we anticipate that the availability of these types of microarray-based testing kits and services will allow epidemiologists to better monitor the spread of pathogens and detect mutations that may alter their potential to cause a pandemic.






Related Links:
Tessare
Affymetrix

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.